Resource Guide: FDA warning Reglan Tardive Dyskinesia

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

Recommended deep-dive

FDA warning Reglan Tardive Dyskinesia: A Detailed Overview

In-depth context and analysis on this topic for researchers and advocates.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.